We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

10 hedge funds and large institutions have $102M invested in Jasper Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $82.2M → $102M (+$20M)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

82% less funds holding

Funds holding: 57 → 10 (-47)

89% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 53

Holders
10
Holders Change
-47
Holders Change %
-82.46%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
2
Reduced
2
Closed
53
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
A
Abingworth
United Kingdom
+$57.5M
2
Citadel Advisors
Citadel Advisors
Florida
+$29.8M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$15.3M
4
Morgan Stanley
Morgan Stanley
New York
+$1.11M
5
Jane Street
Jane Street
New York
+$266K

Top Sellers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
-$6.49M
2
TCM
Tenor Capital Management
New York
-$4.97M
3
FTCM
Fir Tree Capital Management
New York
-$4.83M
4
SCM
Shaolin Capital Management
Florida
-$4.46M
5
WRBC
W.R. Berkley Corp
Connecticut
-$4.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Saba Capital Management
New York
– -$1.87M -18,786 Closed
Verition Fund Management
27
Verition Fund Management
Connecticut
– -$1.51M -15,180 Closed
OCAM
28
Owl Creek Asset Management
New York
– -$1.48M -14,900 Closed
BCM
29
Beryl Capital Management
California
– -$1.36M -13,680 Closed
AFM
30
Anson Funds Management
Texas
– -$1.35M -13,559 Closed
RCM
31
Rivernorth Capital Management
Florida
– -$1.31M -13,141 Closed
BRF
32
B. Riley Financial
California
– -$1.24M -12,446 Closed
Hudson Bay Capital Management
33
Hudson Bay Capital Management
Connecticut
– -$1.1M -11,093 Closed
Bank of America
34
Bank of America
North Carolina
– -$1.1M -11,050 Closed
WAM
35
Weiss Asset Management
Massachusetts
– -$1.07M -10,748 Closed
PCM
36
Prelude Capital Management
New York
– -$1M -10,100 Closed
PC
37
Periscope Capital
Ontario, Canada
– -$998K -10,040 Closed
PMAM
38
Picton Mahoney Asset Management
Ontario, Canada
– -$993K -9,994 Closed
AA
39
AQR Arbitrage
Connecticut
– -$980K -9,852 Closed
Millennium Management
40
Millennium Management
New York
– -$909K -9,144 Closed
Walleye Capital
41
Walleye Capital
New York
– -$867 -8,724 Closed
LCM
42
Landscape Capital Management
New Jersey
– -$844K -8,489 Closed
YCM
43
Yakira Capital Management
Connecticut
– -$828K -8,333 Closed
EAM
44
Exos Asset Management
New York
– -$602K -6,049 Closed
GCL
45
Glazer Capital LLC
New York
– -$590K -5,940 Closed
Walleye Trading
46
Walleye Trading
New York
– -$578K -5,816 Closed
CCM
47
Context Capital Management
California
– -$497K -5,000 Closed
SAM
48
Seelaus Asset Management
New Jersey
– -$453K -4,554 Closed
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
– -$443K -4,448 Closed
WC
50
Wealthspring Capital
New York
– -$430K -4,327 Closed
1
2
3

JSPR Hedge Fund Activity: Q3 2021 in Review

10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q3 2021, worth a combined $102M — up 24% from $82.2M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of JSPR and 6 opened new positions — a net loss of 47 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Abingworth, opening a new position worth an estimated $57.5M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $6.49M sold.

  • 10 institutional investors held Jasper Therapeutics (JSPR) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $102M of Jasper Therapeutics stock for Q3 2021, up 24% quarter-over-quarter.
  • 6 funds opened new Jasper Therapeutics positions in Q3 2021 and 53 closed out, a net change of -47 holders.
  • The largest Jasper Therapeutics buyer in Q3 2021 was Abingworth, an estimated $57.5M added.
  • The largest Jasper Therapeutics seller in Q3 2021 was Mizuho Securities USA, an estimated $6.49M sold.

Based on aggregated 13F filings for Q3 2021.